AbiKO heterozygous embryos display stalling of the ISNb motor nerve at the junction of muscles 6 and 13, with failure to innervate muscle 12 (observed in 31% of examined hemisegments).
AbiP2/AbiKO has abnormal neuroanatomy | embryonic stage phenotype, suppressible | partially by Abl4/Abl[+]
Df(3R)JY19/AbiKO has abnormal neuroanatomy | embryonic stage phenotype, suppressible | partially by Abl4/Abl[+]
Abi[+]/AbiKO is a suppressor | partially of abnormal neuroanatomy | larval stage phenotype of Abl4/Abl1
AbiKO has larval intersegmental nerve branch ISNb of A1-7 | embryonic stage phenotype, enhanceable by SCARΔ37/SCAR[+]
AbiP2/AbiKO has larval longitudinal connective phenotype, suppressible | partially by Abl4/Abl[+]
Df(3R)JY19/AbiKO has larval longitudinal connective phenotype, suppressible | partially by Abl4/Abl[+]
Abi[+]/AbiKO is an enhancer of larval intersegmental nerve branch ISNb of A1-7 | embryonic stage phenotype of SCARΔ37
Abi[+]/AbiKO is a suppressor | partially of NMJ bouton | increased number phenotype of Abl4/Abl1
The frequency of the midline crossing defect seen in Fas-expressing axons in AbiKO/Df(3R)JY19 embryos is suppressed from 32% to 15% by Abl4/+.
The frequency of the midline crossing defect seen in Fas-expressing axons in AbiKO/AbiP2 embryos is suppressed from 9.6% to 3% by Abl4/+.
The increased bouton number per muscle area that is seen at the neuromuscular junction of Abl1/Abl4 larvae is significantly suppressed by AbiKO/+. This suppression further increased if the flies are also carrying enaGC5/+.